News

Patient Dies After Receiving Sarepta’s Gene Therapy
Sarepta Therapeutics said early Tuesday that a patient had died after receiving its gene therapy Elevidys, which treats the ...
MedPage Today1mon
Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy
Opens in a new tab or window A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ... The patient died after experiencing acute liver ...
Monthly Prescribing Reference1mon
Patient Dies Following Treatment With DMD Gene Therapy Elevidys
It was also revealed that the patient had a recent cytomegalovirus infection, which may have contributed to the liver damage. In general, Elevidys therapy should be postponed in patients with ...
STAT1mon
Teenager who received Elevidys, Sarepta’s Duchenne gene therapy, dies
Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne ... have also contributed to the patient’s death, putting him at heightened ...
FiercePharma1mon
Sarepta reports one death after patient received DMD gene therapy Elevidys
One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys ... Elevidys after initially receiving a placebo, Elevidys ...
Morning Call PA1mon
Patient dies following muscular dystrophy gene therapy, Sarepta reports
WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular ... from an Alabama woman after a record 130 days The House ...
Reuters1mon
Sarepta says teen died after its gene therapy treatment
Patient was a 16-year-old teen ... 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy.
U.S. News & World Report1mon
Sarepta’s Gene Therapy Under Scrutiny After Patient Death
WEDNESDAY, March 19, 2025 (HealthDay News) -- A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment.
GEN1mon
DMD Patient Dies After Treatment with Sarepta Gene Therapy
Sarepta Therapeutics said it will update its prescribing information for Elevidys® (delandistrogene moxeparvovec-rokl) after acknowledging the sudden death of a patient with Duchenne muscular ...
Medical Xpress1mon
Sarepta's gene therapy under scrutiny after patient death
A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death linked to the treatment. The company behind the drug, Sarepta ...
Benzinga.com1mon
Patient who received Elevidys, Sarepta's Duchenne gene therapy, dies
Sarepta Therapeutics said Tuesday that a young man died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy. It is the first known death linked to the treatment.